Annual Cash & Cash Equivalents
$245.45 M
+$217.18 M+768.38%
December 31, 2023
Summary
- As of February 7, 2025, MEDP annual cash & cash equivalents is $245.45 million, with the most recent change of +$217.18 million (+768.38%) on December 31, 2023.
- During the last 3 years, MEDP annual cash & cash equivalents has fallen by -$32.32 million (-11.63%).
- MEDP annual cash & cash equivalents is now -46.79% below its all-time high of $461.30 million, reached on December 31, 2021.
Performance
MEDP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$656.90 M
+$146.01 M+28.58%
September 30, 2024
Summary
- As of February 7, 2025, MEDP quarterly cash and cash equivalents is $656.90 million, with the most recent change of +$146.01 million (+28.58%) on September 30, 2024.
- Over the past year, MEDP quarterly cash and cash equivalents has increased by +$146.01 million (+28.58%).
- MEDP quarterly cash and cash equivalents is now at all-time high.
Performance
MEDP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
MEDP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +768.4% | +28.6% |
| 3 y3 years | -11.6% | +64.9% |
| 5 y5 years | +954.6% | +728.5% |
MEDP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.8% | +768.4% | at high | +2224.1% |
| 5 y | 5-year | -46.8% | +768.4% | at high | +2224.1% |
| alltime | all time | -46.8% | +1549.5% | at high | +4704.0% |
Medpace Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $656.90 M(+28.6%) |
| Jun 2024 | - | $510.89 M(+25.5%) |
| Mar 2024 | - | $407.01 M(+65.8%) |
| Dec 2023 | $245.45 M(+768.4%) | $245.45 M(+157.8%) |
| Sep 2023 | - | $95.21 M(+143.3%) |
| Jun 2023 | - | $39.14 M(-16.6%) |
| Mar 2023 | - | $46.92 M(+66.0%) |
| Dec 2022 | $28.27 M(-93.9%) | $28.27 M(-8.8%) |
| Sep 2022 | - | $31.01 M(-27.1%) |
| Jun 2022 | - | $42.55 M(-48.6%) |
| Mar 2022 | - | $82.84 M(-82.0%) |
| Dec 2021 | $461.30 M(+66.1%) | $461.30 M(+15.8%) |
| Sep 2021 | - | $398.39 M(+17.5%) |
| Jun 2021 | - | $339.01 M(+1.8%) |
| Mar 2021 | - | $332.88 M(+19.8%) |
| Dec 2020 | $277.77 M | $277.77 M(+26.7%) |
| Sep 2020 | - | $219.23 M(+36.2%) |
| Jun 2020 | - | $160.90 M(+20.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $134.00 M(+1.6%) |
| Dec 2019 | $131.92 M(+466.8%) | $131.92 M(+66.4%) |
| Sep 2019 | - | $79.29 M(+294.5%) |
| Jun 2019 | - | $20.10 M(-33.3%) |
| Mar 2019 | - | $30.13 M(+29.4%) |
| Dec 2018 | $23.27 M(-12.1%) | $23.27 M(+4.6%) |
| Sep 2018 | - | $22.24 M(+0.1%) |
| Jun 2018 | - | $22.23 M(-0.1%) |
| Mar 2018 | - | $22.25 M(-16.0%) |
| Dec 2017 | $26.48 M(-28.6%) | $26.48 M(+9.6%) |
| Sep 2017 | - | $24.17 M(-16.8%) |
| Jun 2017 | - | $29.05 M(-0.9%) |
| Mar 2017 | - | $29.32 M(-21.0%) |
| Dec 2016 | $37.10 M(+149.3%) | $37.10 M(+153.5%) |
| Sep 2016 | - | $14.64 M(+7.0%) |
| Jun 2016 | - | $13.67 M(-43.5%) |
| Mar 2016 | - | $24.18 M(+62.5%) |
| Dec 2015 | $14.88 M(-72.6%) | $14.88 M |
| Dec 2014 | $54.28 M | - |
FAQ
- What is Medpace Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Medpace Holdings?
- What is Medpace Holdings annual cash & cash equivalents year-on-year change?
- What is Medpace Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Medpace Holdings?
- What is Medpace Holdings quarterly cash and cash equivalents year-on-year change?
What is Medpace Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of MEDP is $245.45 M
What is the all time high annual cash & cash equivalents for Medpace Holdings?
Medpace Holdings all-time high annual cash & cash equivalents is $461.30 M
What is Medpace Holdings annual cash & cash equivalents year-on-year change?
Over the past year, MEDP annual cash & cash equivalents has changed by +$217.18 M (+768.38%)
What is Medpace Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of MEDP is $656.90 M
What is the all time high quarterly cash and cash equivalents for Medpace Holdings?
Medpace Holdings all-time high quarterly cash and cash equivalents is $656.90 M
What is Medpace Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, MEDP quarterly cash and cash equivalents has changed by +$146.01 M (+28.58%)